Literature DB >> 12370461

Midlife adiposity and the future risk of Parkinson's disease.

R D Abbott1, G W Ross, L R White, J S Nelson, K H Masaki, C M Tanner, J D Curb, P L Blanchette, J S Popper, H Petrovitch.   

Abstract

BACKGROUND: Evidence suggests that nigrostriatal system disorders are associated with PD and adiposity. Whether patterns of adiposity coexist or predate clinical PD is unknown. This report examines the relation between midlife adiposity and the risk of PD.
METHODS: Measurement of adiposity occurred from 1965 to 1968 in 7,990 men in the Honolulu Heart Program (aged 45 to 68 years and without PD). Adiposity measures included body mass index (BMI), subscapular skinfold thickness (SSF), and triceps skinfold thickness (TSF). Follow-up for incident PD occurred over a 30-year period.
RESULTS: During the course of follow-up, PD was observed in 137 men. Among the measures of adiposity, age-adjusted incidence of PD increased threefold from 3.7/10,000 person-years in the bottom quartile of TSF (1 to 5 mm) to 11.1/10,000 person-years in the top quartile (11 to 32 mm, p < 0.001). Effects of TSF on PD were independent of cigarette smoking, coffee consumption, physical activity, daily caloric and fat intake, and the other measures of adiposity (p < 0.001). Whereas rates of PD were lowest in the bottom quartile of BMI and SSF vs higher quartiles, associations with PD were weaker than they were for TSF. The effect of TSF on clinical onset before age 65 years was similar to the effect that was observed in later life.
CONCLUSIONS: Increased triceps skinfold thickness measured in midlife is associated with an elevated risk of future PD. Whether patterns of adiposity reflect a unique metabolic pathology in individuals at a high risk of PD warrants further study.

Entities:  

Mesh:

Year:  2002        PMID: 12370461     DOI: 10.1212/wnl.59.7.1051

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  61 in total

1.  Premotor Parkinson's disease: concepts and definitions.

Authors:  Andrew Siderowf; Anthony E Lang
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

2.  Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.

Authors:  Anne-Marie A Wills; Adriana Pérez; Jue Wang; Xiao Su; John Morgan; Suja S Rajan; Maureen A Leehey; Gregory M Pontone; Kelvin L Chou; Chizoba Umeh; Zoltan Mari; James Boyd
Journal:  JAMA Neurol       Date:  2016-03       Impact factor: 18.302

3.  Work, obesity, and occupational safety and health.

Authors:  Paul A Schulte; Gregory R Wagner; Aleck Ostry; Laura A Blanciforti; Robert G Cutlip; Kristine M Krajnak; Michael Luster; Albert E Munson; James P O'Callaghan; Christine G Parks; Petia P Simeonova; Diane B Miller
Journal:  Am J Public Health       Date:  2007-01-31       Impact factor: 9.308

4.  Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease?

Authors:  R J Phillips; G C Walter; S L Wilder; E A Baronowsky; T L Powley
Journal:  Neuroscience       Date:  2008-03-18       Impact factor: 3.590

5.  Dietary fat intake, pesticide use, and Parkinson's disease.

Authors:  Freya Kamel; Samuel M Goldman; David M Umbach; Honglei Chen; Gina Richardson; Marie Richards Barber; Cheryl Meng; Connie Marras; Monica Korell; Meike Kasten; Jane A Hoppin; Kathleen Comyns; Anabel Chade; Aaron Blair; Grace S Bhudhikanok; G Webster Ross; J William Langston; Dale P Sandler; Caroline M Tanner
Journal:  Parkinsonism Relat Disord       Date:  2013-10-01       Impact factor: 4.891

6.  Non-genetic factors associated with the risk of Parkinson's disease in Iranian patients.

Authors:  N Hosseini Tabatabaei; B Babakhani; A Hosseini Tabatabaei; Z Vahabi; A Soltanzadeh
Journal:  Funct Neurol       Date:  2013 Apr-May

Review 7.  Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?

Authors:  Hutan Ashrafian; Leanne Harling; Ara Darzi; Thanos Athanasiou
Journal:  Metab Brain Dis       Date:  2013-05-08       Impact factor: 3.584

8.  Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism.

Authors:  Zane B Andrews; Derek Erion; Rudolph Beiler; Zhong-Wu Liu; Alfonso Abizaid; Jeffrey Zigman; John D Elsworth; Joseph M Savitt; Richard DiMarchi; Matthias Tschoep; Robert H Roth; Xiao-Bing Gao; Tamas L Horvath
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

9.  Midlife milk consumption and substantia nigra neuron density at death.

Authors:  Robert D Abbott; G Webster Ross; Helen Petrovitch; Kamal H Masaki; Lenore J Launer; James S Nelson; Lon R White; Caroline M Tanner
Journal:  Neurology       Date:  2015-12-09       Impact factor: 9.910

10.  Efficacy of a meal replacement diet plan compared to a food-based diet plan after a period of weight loss and weight maintenance: a randomized controlled trial.

Authors:  Lisa M Davis; Christopher Coleman; Jessica Kiel; Joni Rampolla; Tammy Hutchisen; Laura Ford; Wayne S Andersen; Andrea Hanlon-Mitola
Journal:  Nutr J       Date:  2010-03-11       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.